Braun Stacey Associates’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-24,753
Closed -$464K 149
2020
Q4
$464K Buy
+24,753
New +$404K 0.02% 119
2019
Q2
Sell
-292,016
Closed -$8.28M 123
2019
Q1
$8.28M Buy
292,016
+83,570
+40% +$2.44M 0.55% 88
2018
Q4
$5.71M Buy
+208,446
New +$6.75M 0.45% 89
2015
Q3
Sell
-512,819
Closed -$21.7M 269
2015
Q2
$21.7M Buy
512,819
+160,656
+46% +$11.4M 0.92% 30
2015
Q1
$20.9M Sell
352,163
-12,659
-3% -$722K 1.22% 15
2014
Q4
$20.6M Buy
364,822
+3,435
+1% +$184K 1.25% 12
2014
Q3
$16.4M Sell
361,387
-11,601
-3% -$564K 1.01% 43
2014
Q2
$19.2M Sell
372,988
-80,510
-18% -$3.96M 1.14% 25
2014
Q1
$22.1M Sell
453,498
-57,510
-11% -$2.79M 1.3% 12
2013
Q4
$22.2M Sell
511,008
-39,717
-7% -$1.63M 1.27% 16
2013
Q3
$21M Sell
550,725
-7,655
-1% -$269K 1.29% 14
2013
Q2
$17.3M Buy
+558,380
New +$16.7M 1.09% 29

Other funds holding VTRS

Braun Stacey Associates's VTRS Position: Q1 2021 in Review

Braun Stacey Associates sold out of Viatris (VTRS) in Q1 2021, closing a stake of 24,753 shares — an estimated $464K sold.

Braun Stacey Associates first reported a position in VTRS in Q2 2013 and held it in 12 quarters. The position peaked at $22.2M in Q4 2013. 1,116 funds tracked by Wall St. Rank hold VTRS as of Q1 2021.

  • Braun Stacey Associates reported no remaining Viatris position as of Q1 2021 after selling out during the quarter.
  • Braun Stacey Associates sold 24,753 Viatris shares in Q1 2021, an estimated $464K.
  • Braun Stacey Associates first reported a position in Viatris in Q2 2013 and held it in 12 quarters.
  • Braun Stacey Associates's Viatris position peaked at $22.2M in Q4 2013.
  • 1,116 funds tracked by Wall St. Rank held Viatris as of Q1 2021.

Based on Braun Stacey Associates's 13F filing for Q1 2021, filed 28 Apr 2021.